# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Albright's Hereditary Osteodystrophy

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-5 of 5 results.
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
Status: Recruiting
Last Changed: Jul 27, 2020
First Received: Sep 21, 2005
Disease(s): Pseudohypoparathyroidism Type 1A, Albright Hereditary Osteodystrophy
Intervention(s): Neurocognitive and psychosocial testing
Locations: Connecticut Children's Medical Center, Hartford, Connecticut, United States
Theophylline Treatment for Pseudohypoparathyroidism
Status: Recruiting
Last Changed: Sep 14, 2020
First Received: Jan 24, 2017
Disease(s): Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy
Intervention(s): Theophylline, Placebos
Locations: Ashley Shoemaker, Nashville, Tennessee, United States
Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old
Status: Recruiting
Last Changed: Sep 17, 2020
First Received: Sep 16, 2020
Disease(s): Pseudohypoparathyroidism, Albright Hereditary Osteodystrophy, Pseudohypoparathyroidism Type 1a
Intervention(s): Theophylline, Placebo
Locations: Vanderbilt University Medical Center, Nashville, Tennessee, United States
Effect of Theophylline in Pseudohypoparathyroidism
Status: Not yet recruiting
Last Changed: Oct 24, 2018
First Received: Oct 24, 2018
Disease(s): PHP Ia, PHP IB, Php1C
Intervention(s): Theophylline
Resistance to Vitamin D or Parathyroid Hormone
Status: Recruiting
Last Changed: Oct 23, 2020
First Received: Nov 04, 1999
Disease(s): Hypocalcemia, Pseudohypoparathyroidism, Osteomalacia, Rickets, Pseudopseudohpoparathyroidism
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States